Duke-NUS Medical School, Singapore, Singapore.
Dr Yen's Clinic, Taoyuan, Taiwan.
Diabetes Obes Metab. 2024 Nov;26(11):5399-5407. doi: 10.1111/dom.15908. Epub 2024 Aug 29.
To assess the likelihood of dementia in individuals with type 2 diabetes (T2D), distinguishing between those with and without microvascular diseases.
Leveraging the National Health Insurance Research Database in Taiwan, we identified individuals newly diagnosed with T2D from 1 January 2009 through 31 December 2014. Multivariable Cox proportional hazard models were used to compare the risk of outcomes.
Individuals with microvascular disease had a significantly higher risk of all-cause dementia (adjusted hazard ratio [95% confidence interval] 1.13 [1.09, 1.17]) compared with matched individuals without microvascular disease. In addition, individuals with diabetic kidney disease and diabetic neuropathy were associated with a significantly increased risk of Alzheimer's disease (1.16 [1.02, 1.32] and 1.14 [1.03, 1.27]), vascular dementia (1.21 [1.06, 1.38] and 1.14 [1.02, 1.28]) and other dementia (1.11 [1.04, 1.19] and 1.10 [1.04, 1.16]), respectively, compared with those without microvascular disease.
This nationwide cohort study showed that patients with T2D and microvascular disease, particularly diabetic kidney disease and diabetic neuropathy, were associated with a significantly higher risk of Alzheimer's disease, vascular dementia, other dementia and all-cause dementia than those without microvascular disease.
评估 2 型糖尿病(T2D)患者发生痴呆的可能性,区分有和无微血管疾病的患者。
利用台湾全民健康保险研究数据库,我们从 2009 年 1 月 1 日至 2014 年 12 月 31 日确定了新诊断为 T2D 的个体。使用多变量 Cox 比例风险模型比较结局风险。
与无微血管疾病的匹配个体相比,有微血管疾病的个体发生全因痴呆的风险显著更高(调整后的风险比[95%置信区间]为 1.13[1.09,1.17])。此外,患有糖尿病肾病和糖尿病周围神经病变的个体发生阿尔茨海默病(1.16[1.02,1.32]和 1.14[1.03,1.27])、血管性痴呆(1.21[1.06,1.38]和 1.14[1.02,1.28])和其他痴呆(1.11[1.04,1.19]和 1.10[1.04,1.16])的风险显著增加,与无微血管疾病的个体相比。
这项全国性队列研究表明,患有 T2D 和微血管疾病的患者,特别是糖尿病肾病和糖尿病周围神经病变,与阿尔茨海默病、血管性痴呆、其他痴呆和全因痴呆的风险显著增加相关,而与无微血管疾病的患者相比。